The ROTRF is proud to announce that in 2014 it completed its mission and no further funding cycles are planned.
The ROTRF supported important and innovative research projects relevant to organ transplantation, particularly where there was an unmet medical need.
Our priority was to support clinically oriented research projects, such as observational clinical studies or studies that use human transplant samples for laboratory examinations, and to focus on understanding the pathogenesis and prevention of human transplantation diseases, including organ injury and rejection, viral infection, and late graft deterioration. Furthermore, the ROTRF considered funding research that addressed related clinical issues in non-transplant patients, including hepatitis C infection and other viral infections, and inflammatory processes relevant to human organ transplantation. These related clinical issues had to demonstrate their relevance to disease phenotypes in organ transplant patients. The Trustees also considered funding studies that investigated transplant populations, ethics, organ preservation and allocation, and healthcare delivery. Moreover, the ROTRF welcomed research in new emerging technologies that examined the pathogenesis of human disease states in organ transplantation. If animal models were used to complement the clinical research, a higher priority was given to those that simulated pathological states and mechanisms operating in human organ transplantation.